A Rare Case With Arterial and Venous Thrombotic Complications After COVID-19

Abstract Background Recently, it has been reported that there is an increase in the incidence of arterial and venous thrombotic complications associated with severe COVID-19 disease. Studies have revealed the definition of COVID-19-associated coagulopathy as the underlying cause of these complications. With the emergence of hypercoagulability, systemic anticoagulant therapy was required at variable doses and durations in COVID-19 patients. Case Report: We present the case of a 79-year-old female patient who developed ischemic stroke, deep vein thrombosis, and acute pulmonary embolism, respectively, despite the use of anticoagulants since hospitalization for severe COVID-19 disease. Discussion Owing to SARS-CoV2 infection may be accompanied by comorbidities such as hypoxia, immobilization, active cancer, and obesity, close patient monitoring should be performed during the period of active disease and recovery. Conclusion The most important message to be taken from this case is that even in patients using anticoagulants, there is still a higher risk of thrombotic complications.